Pacira BioSciences
PCRX36.4000.25% ( +0.090 )
Closed: Oct 14, 16:00:00 (EDT)Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
Seeking Alpha·- Wall Street healthcare stocks experienced notable fluctuations driven by market updates, including vaccine developers reacting to WHO reports and major sector indices posting weekly gains. - Becton Dickinson agreed to invest $3 billion to expand domestic manufacturing in the U.S., while CSL partnered with Alentis in a $1.55 billion deal for rare disease treatments. - Viatris announced a definitive agreement to acquire Pacira BioSciences for $1.65 billion in cash to advance its innovative medicines strategy.Nasdaq Falls Over 300 Points as Oil Prices Surge: Investor Sentiment Weakens, Fear & Greed Index Remains in ‘Fear’ Zone
benzinga_article·- U.S. stocks settled mostly lower on Thursday as the Nasdaq dropped over 300 points amid surging oil prices driven by Persian Gulf tanker attacks. - The CNN Money Fear and Greed index declined to a reading of 38, remaining in the "Fear" zone. - Initial jobless claims fell by 2,000 to 197,000 for the week ending Oct. 3, while companies like PepsiCo reported strong third-quarter earnings.